{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective from the specified list.", "method": "llm_batch", "batch_id": "batch_1_5640", "batch_size": 200, "batch_pos": 22, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The verbs ('secures', 'includes an option') and descriptions of scale ('up to 665,000 doses', '40 million vaccines') are neutral.", "method": "llm_batch", "batch_id": "batch_2_10616", "batch_size": 200, "batch_pos": 196, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "'secures' is a factual verb. Scale is present but not paired with a moderate verb describing impact.", "method": "llm_batch", "batch_id": "batch_3_17212", "batch_size": 200, "batch_pos": 165, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_19220", "batch_size": 200, "batch_pos": 162, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports a fact but contains no explicit calming cues.", "method": "llm_batch", "batch_id": "batch_5_18760", "batch_size": 200, "batch_pos": 158, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_2460", "batch_size": 200, "batch_pos": 133, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation or an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_7_18512", "batch_size": 200, "batch_pos": 128, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes securing 'up to 665,000 doses' and an 'option for a further 40 million vaccines', stockpiling/capability measures.", "method": "llm_batch", "batch_id": "batch_8_16136", "batch_size": 200, "batch_pos": 26, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
